<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04634786</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02305-34</org_study_id>
    <nct_id>NCT04634786</nct_id>
  </id_info>
  <brief_title>Association Between CRSA and OSA</brief_title>
  <acronym>CRSA</acronym>
  <official_title>The Association Between Central Serous Chorioretinopathy and the Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This goal of this study is to know the association between the central serous&#xD;
      chorioretinopathy and the obstructive sleep apnea. Many studies have been done in order to&#xD;
      assess the association between the central serous chorioretinopathy and obstructive sleep&#xD;
      apnea and the results are always controverses actually.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2021</start_date>
  <completion_date type="Anticipated">August 6, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 6, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association between central serous chorioretinopathy and the obstructive sleep apnea.</measure>
    <time_frame>During 3 months we will collect the results of Berlin survey.</time_frame>
    <description>Percentage of high risks of obstructive sleep apnea in patients affected by central serous chorioretinopathy in using the Berlin survey.&#xD;
The Berlin questions include 3 categories:&#xD;
The category 1 is positive if 2 answers are positive. The category 2 is positive if 2 answers are positive. The category 3 is positive if 1 answer is positive. Finally, if 2 categories are positive, the patient is considered as high risk of obstructive sleep apnea.</description>
  </primary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Chorioretinopathy</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The central serous chorioretinopathy is defined by RSD (retinal serous detachment) located&#xD;
        to the macula, it must be diagnosed since 6 months.&#xD;
&#xD;
        Patients with central serous chorioretinopathy will undergo a Berlin Questions to assess&#xD;
        the risks to have an obstructive sleep apnea.&#xD;
&#xD;
        More over, we measure the choroid's thickness by using EDI OCT(Enhanced depth imaging&#xD;
        optical coherence tomography) The survey and the measure of the choroid's thickness will be&#xD;
        performed during an ophthalmology routing consultation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Central serous chorioretinopathy since 6 months at least&#xD;
&#xD;
          -  Patients beyond 18 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - All retina pathology will be excluded : diabetes with affected retina, maculopathy,&#xD;
        retina central veinous oclusion, epith√©liopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicolas LEVEZIEL, Pr</last_name>
    <phone>0549444182</phone>
    <phone_ext>+33</phone_ext>
    <email>nicolas.leveziel@chu-poitiers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas LEVEZIEL, Pr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

